# NEOLPHARMA, INC. – FDA Inspection, Jun 7, 2017

Source: https://www.keypedia.com/records/fda_inspections/neolpharma-inc/28c019ed-583a-478d-80cf-0d3e38d635c3
Source feed: FDA_Inspections

> FDA inspection 1018694 of NEOLPHARMA, INC., June 07, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1018694
- Company Name: NEOLPHARMA, INC.
- Inspection Date: 2017-06-07
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1304150 - 2026-03-10](https://www.keypedia.com/records/fda_inspections/neolpharma-inc/0f95eddc-787e-4d59-aecb-be0b8a4ebb5a)
- [FDA Inspection 1166181 - 2022-04-01](https://www.keypedia.com/records/fda_inspections/neolpharma-inc/333f1bda-c222-419f-af7c-dea739c8f225)
- [FDA Inspection 1078192 - 2019-02-05](https://www.keypedia.com/records/fda_inspections/neolpharma-inc/a81b069e-73c1-4020-b82d-ac7363881d3b)
- FDA Inspection 929761 - 2015-06-18
- FDA Inspection 822275 - 2013-03-07

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/libia-m-lugo/893802aa-76a6-4fb5-ab71-eaee099e4f67)
- Issuing Officer

Company: https://www.keypedia.com/companies/neolpharma-inc/4a216d1c-7206-434a-82df-ca1a8f1fe43b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
